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Fc Receptor-Mediated Immunity Against Bordetella pertussis1
Maria Eugenia Rodriguez,2*‡ Sandra M. M. Hellwig,*§ Daniela F. Hozbor,‡ Jeanette Leusen,*
W. -Ludo van der Pol,3* and Jan G. J. van de Winkel*†
The relevance of specific Abs for the induction of cellular effector functions against Bordetella pertussis was studied. IgG-opsonized
B. pertussis was efficiently phagocytosed by human polymorphonuclear leukocytes (PMN). This process was mediated by the PMN
IgG receptors, FcgRIIa (CD32) and FcgRIIIb (CD16), working synergistically. Furthermore, these FcgR triggered efficient PMN
respiratory burst activity and mediated transfer of B. pertussis to lysosomal compartments, ultimately resulting in reduced
bacterial viability. Bacteria opsonized with IgA triggered similar PMN activation via FcaR (CD89). Simultaneous engagement of
FcaRI and FcgR by B. pertussis resulted in increased phagocytosis rates, compared with responses induced by either isotype alone.
These data provide new insights into host immune mechanisms against B. pertussis and document a crucial role for Ig-FcR
interactions in immunity to this human pathogen. The Journal of Immunology, 2001, 167: 6545–6551.
Bordetella pertussis is the causative agent of whoopingcough. It produces numerous toxins and adhesins such aspertussis toxin, adenylate cyclase-hemolysin toxin, tra-
cheal cytotoxin, dermonecrotic toxin, filamentous hemagglutinin
(FHA),4 pertactin, fimbriae, and Bordetella resistant to killing pro-
tein, which have all been implicated to play a role in disease patho-
genesis (1, 2). Both whole cell and acellular pertussis vaccines
induce high levels of specific Abs directed against several viru-
lence factors. Although the mechanisms by which Abs contribute
to host protection are largely unclear, experimental data support
their relevance for the induction of immunity to B. pertussis (3–5).
B. pertussis resides at the mucosa of the respiratory tract during
infection. It is capable of attaching to epithelial as well as immune
cells, such as mononuclear leukocytes (MN) (6–10). Attachment
to respiratory tract epithelia proposedly precedes invasion of epi-
thelial cells, which might ensure bacterial immune evasion during
host infection (11, 12). In addition, B. pertussis may evade innate
host defense by favoring specific, nonbactericidal interaction with
MN and polymorphonuclear leukocytes (PMN). It has been shown
that complement receptor 3 (CR3/(CD11b/CD18)) on monocytes
can serve as a “docking site” for B. pertussis by binding FHA (13,
14). In addition, bacterial constituents including fimbriae, pertussis
toxin, and FHA up-regulate CR3 expression, suggesting that non-
opsonized B. pertussis may stimulate its own attachment to im-
mune cells (9, 13, 15). Both in vitro and in vivo studies pro-
vided evidence that uptake via CR3 does not lead to efficient
bacterial killing by phagocytes, thus favoring intracellular sur-
vival (7, 16, 17).
The presence of specific Abs may alter the interaction of B.
pertussis with phagocytes. Both MN and PMN express several
classes of Ig receptors (FcR) which, upon interaction with immune
complexes such as opsonized bacteria, are capable of initiating
potent cellular effector functions. Leukocyte IgG receptors (FcgR)
are grouped into three classes (FcgRI (CD64), FcgRII (CD32), and
FcgRIII (CD16)), each of which encompasses a number of sub-
classes (18, 19). Members of all FcgR classes can be expressed on
mononuclear cells (i.e., FcgRIa, FcgRIIa, and FcgRIIIa), whereas
PMN constitutively express FcgRIIa and FcgRIIIb. In addition,
MN and PMN also express an IgA receptor (FcaRI (CD89)) which
is capable of triggering antibacterial effector functions (20–22).
Insight into the relevance of specific Abs for phagocytosis of B.
pertussis is incomplete and previous studies have yielded conflict-
ing results (23–28). In this study, we examined the relevance of
FcR for the induction of Ig-triggered cellular effector functions
against B. pertussis.
Materials and Methods
Bacterial strains and growth conditions
B. pertussis strain B213, a streptomycin-resistant derivative of Tohama,
was used in this study. The virulent B. pertussis B213 were transformed
with plasmid pCW505 (Ref. 25; kindly supplied by Dr. Weiss, Cincinnati,
OH) which induces cytoplasmic expression of green fluorescent protein
(GFP) without affecting growth or Ag expression (25). Bacteria were
stored at 270°C and recovered by growth on Bordet-Gengou (BG)
agar plates at 35°C for 3 days. Virulent bacteria were subsequently plated
on BG plates, cultured overnight, and used in phagocytosis experi-
ments. Green fluorescence of GFP-modified bacteria was checked in every
experiment.
Antibodies
mAb 22 (mouse (m) IgG1, anti-human (h) FcgRI), mAb IV3 (mIgG2b and
F(ab9), anti-hFcgRII), and mAb 3G8 (mIgG1 and F(ab9)2, anti-hFcgRIII)
were purchased from Medarex (Annandale, NJ). FcaRI-blocking Ab My43
(mIgM) was a generous gift from Dr. L. Shen (29). mAbs against human
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lysosome-associated membrane protein (LAMP)-1 (mIgG1) and human
LAMP-2 (mIgG1) were from BD PharMingen (San Diego, CA).
IgG fractions from pooled sera of pertussis patients5 with high titers
against B. pertussis (as measured by ELISA; Ref. 30) were obtained using
protein G (Pharmacia Biotech, Uppsula, Sweden) chromatography fol-
lowed by acidic elution. Sera of pertussis patients5 with high B. pertussis-
specific IgA titers (measured by ELISA; Ref. 31) were pooled and IgA was
purified using Affi-T (Biozym, Landgraaf, The Netherlands; Ref. 32) and
size chromatography (Superdex 200; Pharmacia Biotech). Isotype purity of
IgG and IgA fractions was verified by electrophoresis on 4–15% SDS
PAGE (Phast Gels; Pharmacia Biotech), followed by Coomassie brilliant
blue staining. Samples of purified IgG, monomeric IgA, and secretory IgA
(all from ICN, Zoetermeer, The Netherlands) were run in parallel lanes and
served as controls. Western blot analyses were performed to exclude the
presence of contaminating isotypes. Polyclonal rabbit anti-B. pertussis an-
tiserum was generated by immunizing rabbits with pertussis whole-cell
vaccine (National Institute of Health and the Environment, Bilthoven, The
Netherlands) as described elsewhere (17). Briefly, rabbits were immunized
and boostered at 3 and 6 wk. Sera were collected 7 wk after primary
immunization. Rabbit IgG was isolated by protein G chromatography
(Pharmacia Biotech) and samples were checked by 4–15% SDS PAGE.
Cells
Peripheral blood PMN were isolated from heparinized venous blood using
Ficoll-Histopaque (Sigma-Aldrich, St. Louis, MO) gradient centrifugation.
Polymorphic leukocytes were harvested and the remaining erythrocytes
removed by hypotonic lysis. Cell viability was .99% as determined by
trypan blue exclusion. Before functional assays, PMN were washed twice
with RPMI 1640 medium supplemented with 10% heat-inactivated FCS,
resuspended, and used immediately. All experiments described in this
study were conducted with freshly isolated PMN lacking FcgRI expres-
sion, as monitored by FACS analysis with FITC-conjugated anti-FcgRI
mAb 22. (33)
Phagocytosis
Phagocytosis of B. pertussis was evaluated as in Ref. 34 with minor mod-
ifications. Briefly, wild-type or GFP-expressing B. pertussis were grown
overnight on BG agar plates and resuspended in RPMI 1640 medium con-
taining 10% FCS. Bacteria were opsonized with human IgG or human IgA
or both human IgG and human IgA (IgG/IgA ratio 2:1, 1:2, or 1:1 w/w) for
30 min at 37°C. Initial pilot experiments showed B. pertussis phagocytosis
to be dose-dependent in the range of 0–200 mg/ml. For additional exper-
iments, 200 mg/ml IgG or IgA were used for opsonization, unless specified
otherwise. Aliquots were analyzed by flow cytometry after incubation with
PE-conjugated goat F(ab9)2 of anti-human IgG or PE-conjugated goat
F(ab9)2 of anti-human IgA (from Southern Biotechnology Associates, Bir-
mingham, AL). After washing, opsonized and nonopsonized bacteria were
incubated with phagocytic cells in a 70:1 ratio for 45 min at 4°C to allow
binding of bacteria to PMN. Nonopsonized bacteria served as a control in
all phagocytosis experiments. In select experiments, 200 ng/ml cytochala-
sin D (Sigma-Aldrich) was added to inhibit phagocytosis (35). After ex-
tensive washing to remove nonattached bacteria, cells were split in two
aliquots and further incubated for 30 min, either at 4 or 37°C. Next, re-
maining cell surface-bound opsonized bacteria were detected by incubation
(30 min at 4oC) with PE-conjugated goat F(ab9)2 of anti-human IgG or
PE-conjugated goat F(ab9)2 of anti-human IgA. In experiments performed
with nonopsonized bacteria, surface-bound bacteria were detected by in-
cubation with rabbit anti-B. pertussis IgG, followed by incubation with
PE-conjugated goat F(ab9) of anti-rabbit IgG (Molecular Probes, Eugene,
OR). After washing, samples were analyzed by flow cytometry. Five-thou-
sand cells were analyzed per sample. Green and red fluorescence intensities
of cells maintained at 4°C throughout served as control for bacterial bind-
ing (i.e., 0% phagocytosis). The decrease in red fluorescence of green pos-
itive cells after incubation at 37°C reflects bacterial phagocytosis, as con-
firmed microscopically (see below). Phagocytosis rates were calculated
from the drop in mean red fluorescence intensity of green-positive cells, as
described (34).
Controls to exclude autofluorescence of PMN or unspecific binding of
F(ab9) of PE-secondary Abs to PMN were included in each experiment.
Phagocytosis of unlabeled bacteria was performed as outlined above, al-
though in this experimental set-up, bacteria were detected by a two-step
labeling procedure after phagocytosis. For this purpose, bacteria were in-
cubated with polyclonal rabbit anti-B. pertussis antiserum, followed by
incubation with FITC-conjugated goat F(ab9)2 of anti-rabbit Ab (The Jack-
son Laboratory, Bar Harbor, ME) to label extracellular bacteria. IgG op-
sonins were detected as described above by incubation with PE-conjugated
goat F(ab9)2 of anti-human IgG.
In some experiments, FcaRI and FcgR-mediated phagocytosis were
studied with and without simultaneous engagement of the other FcR class.
For this purpose, PMN were incubated with both IgG (or IgA) opsonized
GFP-labeled bacteria and IgA (or IgG) opsonized bacteria without a flu-
orescent label. Internalization of GFP-labeled bacteria was assessed as de-
scribed above by incubation with PE-labeled F(ab9)2 directed against the
opsonin on fluorescently labeled bacteria.
In select experiments, bacterial phagocytosis was evaluated microscop-
ically. For this purpose, cell surface-bound IgG-opsonized bacteria were
detected by incubation (30 min at 4oC) with tetramethylrhodamine isothio-
cyanate-conjugated goat anti-human IgGkl antiserum (Southern Biotech-
nology Associates).
Respiratory burst
B. pertussis was opsonized by incubation with either IgG or IgA as de-
scribed above. Tubes containing 50 ml with 7 3 106 opsonized (or non-
opsonized) bacteria were transferred to a luminometer (Autolumat; Wallac,
Berthhold, Germany), in which chemoluminescence responses of 105 PMN
were measured every min for 30 min at 37°C after injection of 600 ml of
180 mM of luminol (Sigma-Aldrich) (36).
Microscopic evaluation of internalization and colocalization of
B. pertussis with LAMP-1
Phagocytosis and intracellular trafficking of B. pertussis were studied mi-
croscopically. Aliquots of neutrophils incubated either at 4 or 37°C during
phagocytosis experiments were fixed using 3% paraformaldehyde. After
fixation, PMN were washed twice with PBS and incubated for 10 min at
room temperature with PBS containing 50 mM of NH4Cl. After two wash-
ing steps, cells were permeabilized by incubation with PBS containing
0.1% saponin (Sigma-Aldrich) and 0.2% BSA for 30 min. Next, cells were
incubated for 30 min at 4°C with rabbit anti-B. pertussis Abs and either
mouse anti-human LAMP-1 or mouse anti-human LAMP-2 mAbs in the
presence of 0.1% saponin and 0.2% BSA. After washing three times, PMN
were incubated (20 min) with CY-3-conjugated sheep anti-rabbit IgG (The
Jackson Laboratory) and FITC-conjugated F(ab9)2 of goat anti-mouse IgG1
(Southern Biotechnology Associates). Finally, cells were spun on micro-
scope slides. Microscopic analyses were performed using a confocal laser
scanning microscope (Leica, Heidelberg, Germany).
Killing assay
Opsonized (either IgG, IgA, or both) or nonopsonized B. pertussis were
allowed to attach to human PMN at 4°C for 30 min. Nonadherent bacteria
were removed by washing and samples were split in two aliquots and
incubated either at 4 or 37°C. To determine the number of bacteria initially
attached to PMN (N4), serial dilutions from samples kept at 4°C throughout
the experiment were prepared and plated in triplicate on BG agar. Simi-
larly, serial dilutions of samples incubated for 30 min at 37°C were pre-
pared and plated on BG agar to determine the number of surviving bacteria
after incubation at 37°C (N37). The percentage of bacteria killed by PMN
was calculated as follows: the percentage of killing5 1003 (12 N37/N4).
Bacterial phagocytosis rates were determined in parallel by flow cytometry
as described above.
Statistics
Student’s t tests served to assess the significance of differences. Signifi-
cance was accepted at the p , 0.05 level.
Results
Phagocytosis of B. pertussis was evaluated by a two-color flow
cytometric assay that provides information about both the attach-
ment and internalization of bacteria. Importantly, this method en-
ables the accurate determination of phagocytosis, without loss of
read-out sensitivity due to quenching of fluorescence upon phago-
cytosis (34).
Purified IgG fractions from the sera of B. pertussis-infected in-
dividuals promoted efficient attachment and phagocytosis of B.
pertussis. In the absence of Abs, bacterial attachment was much
lower and no significant internalization could be observed. Fig. 1
5 Written informed consent was obtained before enrollment. This study was approved
by the institutional review board of the National Institute of Public Health and the
Environment, Bilthoven, The Netherlands.
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shows dot-plot diagrams of green and red fluorescence intensities
of PMN incubated with nonopsonized, or IgG-opsonized, bacteria.
Bacterial attachment is reflected by green fluorescence associated
with PMN kept at 4°C, whereas phagocytosis is reflected by the
decrease of PMN-associated red fluorescence after incubation at
37°C. IgG from nonimmunized individuals with undetectable Ab
titers against B. pertussis did not induce phagocytosis. Results
were comparable to those obtained with nonopsonized bacteria
(data not shown)
To confirm that the drop in PE-fluorescence of PMN incubated
at 37°C was attributable to bacterial phagocytosis, PMN were in-
cubated with cytochalasin D. Similar results were obtained as with
controls maintained at 4°C, confirming the decrease of red fluo-
rescence intensity at 37°C to result from bacterial ingestion (n 5
3, data not shown). We further assessed phagocytosis of B. per-
tussis microscopically. Fig. 2 shows PMN kept at 4°C to display
both green and red fluorescence, whereas most of the bacteria as-
sociated with PMN incubated at 37°C display green fluorescence
only (ingested bacteria). Confocal microscopy of nonopsonized B.
pertussis showed bacteria to be attached to a low number of PMN
and not to be internalized at 37°C (data not shown). Although GFP
expression has been reported not to influence B. pertussis phago-
cytosis (25), wild-type bacteria (lacking the plasmid for GFP ex-
pression) were tested in control experiments. For this purpose, rab-
bit anti-B. pertussis Abs were used to label extracellular bacteria.
Essentially, similar results were obtained with GFP-transformed
and wild-type bacteria, confirming that GFP expression does not
influence B. pertussis phagocytosis (data not shown, n 5 3)
We next evaluated the role of FcgR in IgG-mediated phagocy-
tosis. IgG-induced phagocytosis proved dependent on both PMN
FcgRIIa and FcgRIIIb. Both attachment and phagocytosis of IgG-
opsonized B. pertussis were significantly reduced by incubation of
PMN with either F(ab9) of CD32 or F(ab9)2 of CD16-blocking
Abs, whereas attachment of nonopsonized bacteria was unaffected.
Moreover, in the presence of both F(ab9) of CD32 and F(ab9)2 of
CD16-blocking Abs, attachment of IgG-opsonized B. pertussis
was abolished (Fig. 3). Consistent differences in dot-blot patterns
were observed when the binding of IgG-opsonized bacteria to ei-
ther FcgRIIa or FcgRIIIb were selectively blocked. Blocking
FcgRIIa resulted in a higher ratio of red to green fluorescence
associated with PMN, compared with that detected when
FcgRIIIb-mediated attachment was blocked. This result suggests
highly opsonized bacteria to preferably attach to FcgRIIIb,
whereas lower levels of opsonization seem to direct bacteria to
FcgRIIa (Fig. 3).
Both IgG and IgA isotypes have been implicated in host defense
against bacterial infections (17, 22, 37). IgA represents the most
prevalent Ig isotype at mucosal sites. Previous studies showed IgA
to induce effective phagocytosis of B. pertussis and other respira-
tory pathogens via FcaRI (22, 38). Because IgG and IgA are both
present at mucosal sites (39), we assessed the capacity of IgA plus
IgG to induce cellular effector functions against B. pertussis. Sim-
ilar to IgG, and consistent with previous observations (38), IgA
was found to enhance bacterial attachment and promote efficient
phagocytosis (Fig. 4). FcaRI showed to be crucial for IgA-medi-
ated functions, because incubation with mouse IgM anti-CD89
mAb My43 (29) completely prevented bacterial attachment (data
not shown, n 5 3). Both attachment to PMN and internalization of
bacteria opsonized with both IgA and IgG increased in an additive
manner, compared with bacteria opsonized with one isotype (Fig.
5). To further study interaction of FcaRI and FcgR, phagocytosis
of GFP-expressing bacteria opsonized with IgA was evaluated in
the presence of unlabeled bacteria opsonized with IgG, and vice
versa. In this way, the effect of FcgR engagement on FcaRI-me-
diated phagocytosis and FcaRI cross-linking on FcgR-mediated
phagocytosis was studied. Efficiency of either FcgR- or FcaR-
mediated phagocytosis was not influenced by simultaneous en-
gagement of the other FcR class at IgG/IgA ratios (w/w) of 1:1,
1:2, or 2:1 (data not shown, n 5 3).
Both IgG- and IgA-opsonized B. pertussis induced significant
respiratory burst responses in human PMN with no activity de-
tected with nonopsonized bacteria (Fig. 6). These experiments
documented the capacity of specific Abs to induce cellular effector
functions against B. pertussis. Because some pathogenic bacteria,
FIGURE 1. Effect of IgG opsonization on attachment and phagocytosis
of B. pertussis by human PMN. Nonopsonized or IgG-opsonized GFP-
expressing B. pertussis were incubated with PMN at 4°C for 30 min. Cells
were split over two aliquots and subsequently incubated for 30 min at
either 4 or 37°C. Remaining surface-bound IgG-opsonized B. pertussis
were detected by addition of PE-conjugated goat F(ab9)2 of anti-human
IgG Abs. Incubation with rabbit anti-B. pertussis IgG, followed by PE-
conjugated goat F(ab9) of anti-rabbit IgG, was used to detect nonopsonized
bacteria bound to the surface of PMN. The experiment was repeated five
times with PMN isolated from different donors, yielding essentially iden-
tical results.
FIGURE 2. Confocal laser scanning fluorescence microscopy of B. per-
tussis phagocytosis. IgG opsonized GFP-labeled B. pertussis were incu-
bated with PMN for 30 min at 4°C, washed, and further incubated for 30
min either at 4°C (A) or at 37°C (B). Cells were then stained with tetra-
methylrhodamine isothiocyanate-conjugated goat anti-human IgG and
spun onto microscope slides for examination. Cell surface-attached bacte-
ria exhibit both green and red fluorescence, whereas ingested bacteria ex-
hibit green fluorescence only. Representative panels of one of four inde-
pendent experiments are shown.
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including B. pertussis, are capable of influencing intracellular traf-
ficking after phagocytosis (40), we next studied whether uptake of
B. pertussis leads to transportation to phagolysosomes and cellular
bactericidal activity. Aliquots of PMN with either adherent IgG-
opsonized B. pertussis (after incubation at 4°C) or internalized B.
pertussis (after incubation at 37°C) were stained with mAb specific
for LAMP and Abs directed to B. pertussis to determine colocal-
ization (thereby assessing intracellular trafficking of bacteria after
uptake). At 4°C, bacteria were only detected at the PMN surface.
Accordingly, no colocalization of bacteria (red fluorescence) and
LAMP-1 (green fluorescence) could be observed (Fig. 7A). Fol-
lowing 30 min of incubation at 37°C, colocalization of B. pertussis
with LAMP-1 (yellow areas) (Fig. 7B) as well as LAMP-2 (data
not shown, n 5 2) was observed, suggesting transport of IgG-
opsonized B. pertussis to lysosomal compartments upon internal-
ization. Incubation of PMN with either CD32- or CD16-blocking
Abs before experiments demonstrated both FcgRIIa and FcgRIIIb
to be capable of shuttling B. pertussis to LAMP-containing sub-
cellular compartments. Similar results were obtained with IgA-
opsonized bacteria, indicating FcaRI-IgA interaction to initiate
trafficking of B. pertussis to lysosomal compartments as well (Fig.
7, C and D).
We next evaluated the viability of Ig-opsonized and nonopso-
nized B. pertussis after incubation with PMN. Bacterial killing was
determined from the difference between the numbers of viable bac-
teria initially attached to PMN (cells incubated at 4°C) and after
bacterial phagocytosis (cells incubated at 37°C). Both IgG- and
IgA- mediated phagocytosis proved to induce efficient bacterial
killing, at an average of 85% (SD56 11, n5 6), and 70% (SD5
6 7, n 5 6), respectively. Importantly, no significant killing was
observed in the absence of Abs. Microbial killing correlated well
with bacterial phagocytosis rates detected flow cytometrically
(data not shown).
Discussion
In this paper, we document specific Abs to efficiently induce cel-
lular anti-B. pertussis effector functions via interaction with FcR
FIGURE 4. IgA-mediated PMN phagocytosis of B. pertussis. Isolated
PMN were incubated at 4°C for 30 min with IgA-opsonized GFP-express-
ing B. pertussis and were further incubated for 30 min, either at 4 or 37°C.
Remaining surface-bound B. pertussis were detected by the addition of
PE-conjugated goat F(ab9)2 of anti-human IgA Abs. Representative dot-
plot diagrams are shown. The experiment was repeated five times yielding
similar results.
FIGURE 3. Role of FcgR in B. pertussis phagocytosis by PMN. A, IgG-opsonized GFP-expressing B. pertussis were incubated with PMN alone or in
the presence of FcgRIIa-blocking mAb IV3, FcgRIIIb-blocking mAb 3G8, or both mAb at 4°C for 30 min. Cells were split over two aliquots and
subsequently incubated for 30 min at either 4 or 37°C. Remaining surface-bound IgG-opsonized B. pertussis were detected by addition of PE-conjugated
goat F(ab9)2 of anti-human IgG Abs. B, Phagocytosis of IgG opsonized B. pertussis by PMN in the absence (control) or in the presence of F(ab9) of
FcgRIIa-blocking mAb IV3, F(ab9)2 of FcgRIIIb-blocking mAb 3G8, or both. Data represent the mean 6 SD of four experiments with PMN from different
donors. AU, arbitrary units.
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on human neutrophils. Ig-opsonization increased B. pertussis at-
tachment, phagocytosis and respiratory burst activity via interac-
tion with FcgRIIa, FcgRIIIb, or FcaRI. Furthermore, engagement
of these FcR initiated transport of B. pertussis to lysosomal com-
partments. These events ultimately lead to decreased bacterial
viability.
B. pertussis represents an important respiratory pathogen caus-
ing significant morbidity, as well as mortality, in nonvaccinated
infants. Although a number of vaccines have been shown to be
effective in preventing disease, recent reports on pertussis out-
breaks in highly vaccinated populations underline the necessity to
assess the mechanisms of immunity to B. pertussis in better detail
(41–43). Vaccination induces Abs against a number of B. pertussis
Ags. High titers of specific Abs have been reported to induce pro-
tection (4, 5), although experimental studies exploring the rele-
vance of Abs for immunity to B. pertussis yielded contradictory
results. Until now, the contribution of Ig-induced phagocytosis to
B. pertussis immunity remained unclear (23–28). To address this
issue in more detail, we used a flow cytometry-based phagocytosis
assay, which allows discrimination of bacterial attachment and
phagocytosis, as well as quantitation of phagocytosis. Efficient
phagocytosis of B. pertussis by PMN was induced by both IgG and
IgA, the main Ig isotypes induced by vaccination. Previous studies
using fluorescence microscopy techniques to assess phagocytosis
mediated by human sera failed to report significant B. pertussis
phagocytosis (23, 25). However, such techniques have the intrinsic
drawback that read-out sensitivity (i.e., fluorescence of internal-
ized bacteria) is significantly decreased by the low pH in phagoly-
sosomes, as well as lengthy quantification procedures. Therefore,
these older studies may well have underestimated Ig-mediated
phagocytosis of B. pertussis.
Phagocytosis of B. pertussis was studied qualitatively with
mAbs blocking specific FcR. Internalization of Ig-opsonized B.
FIGURE 6. Induction of PMN respiratory burst by B. pertussis opso-
nized with either IgG or IgA. IgG-opsonized, IgA-opsonized, or nonopso-
nized B. pertussis were incubated with PMN and luminol at 37°C. PMN
incubated with buffer served as a control. Chemoluminescence responses
were measured every min for 30 min. Data are representative of four in-
dependent experiments.
FIGURE 5. Effect of IgA and IgG opsonization on the uptake of B. pertussis by PMN. A, PMN were incubated with B. pertussis opsonized either with
IgG, IgA, or IgG plus IgA at 4°C during 30 min. Cells were split over two aliquots and subsequently incubated for 30 min at either 4 or 37°C. The remaining
surface-bound opsonized B. pertussis were detected by addition of PE-conjugated goat F(ab9)2 of anti-human IgG Abs, PE-conjugated goat F(ab9)2 of
anti-human IgA Abs, or both. B, Phagocytosis of IgG-, IgA-, or IgG- plus IgA-opsonized B. pertussis by PMN. Data represent the mean 6 SD of four
experiments with PMN from different donors. AU, arbitrary units.
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pertussis was mediated via both PMN IgG, as well as IgA recep-
tors. Optimal IgG-mediated phagocytosis was shown to depend on
employment of neutrophil FcgR, FcgRIIa, and FcgRIIIb. These
results are in agreement with previous reports documenting het-
erotypic cross-linking of FcgRIIa and FcgRIIIb to induce syner-
gistic PMN responses (44–47). Interestingly, specific FcgR sub-
class engagement by opsonized bacteria seems to depend on the
level of bacterial opsonization. FcgRIIIb was primarily involved in
the binding of highly opsonized bacteria, whereas bacteria with
lower levels of opsonization attached well to FcgRIIa (Fig. 3A).
These findings corroborate and extend previous studies document-
ing high valency immune complexes to activate PMN primarily
via FcgRIIIb (44, 45, 48). Furthermore, IgA-opsonized B. pertus-
sis was taken up efficiently via interaction with FcaRI and induced
PMN respiratory burst activity. These results suggest that FcaRI
constitute an important molecule for immunity not only against
Gram-positive bacteria (22), but also against Gram-negative bac-
teria. Importantly, IgA and IgG are both relevant for host immu-
nity to pathogens at mucosal sites (39). Therefore, phagocytosis of
B. pertussis opsonized with both isotypes was evaluated. Simul-
taneous stimulation of FcgR and FcaRI induces a phagocytic re-
sponse which was approximately the sum of FcgR- and FcaRI-
mediated activities, suggesting simultaneous FcR cross-linking to
constitute an important host-defense mechanism at mucosal sites.
A number of human pathogens are capable of evading host im-
munity by interfering with phagosome-lysosome fusion. B. per-
tussis has been reported to be able to survive after uptake in pro-
fessional phagocytes by inhibiting the formation of phagoly-
sosomes (24). However, results from recent studies using murine
macrophages challenged this concept, because B. pertussis was
found to be transported to lysosomal compartments after internal-
ization and to be effectively killed upon phagolysosome formation
(49). B. pertussis is a strictly human pathogen and mouse models
may have limited value for our understanding of human immunity.
Using human PMN, we found IgA- and IgG-opsonized bacteria to
be efficiently transported to lysosomal compartments upon inter-
nalization. Bacteria could be observed in LAMP-containing com-
partments of neutrophils as soon as after 30 min. It was recently
shown that the presence of an immunoreceptor tyrosine-based ac-
tivation motif (ITAM) is sufficient to initiate transport of internal-
ized particles to lysosomes (50). Both FcgRIIa and FcaRI initiate
signal transduction upon cross-linking via ITAM-signaling motifs
(51). However, engagement of FcgRIIIb, which lacks ITAM, in-
duced internalization and trafficking of B. pertussis to lysosomal
compartments as well. GPI-linked FcgRIIIb may use FcgRIIa or
other associated molecules for signaling, leading to efficient trans-
port to lysosomes, or may trigger lysosome formation via ITAM-
independent pathways (45, 52, 53).
Finally, killing assays indicated that bacterial uptake, induction
of respiratory burst activity, and formation of phagolysosomes in-
duced efficient killing of IgG- and IgA- opsonized B. pertussis. In
the absence of specific Abs, binding of B. pertussis to human neutro-
phils was significantly lower and neither efficient phagocytosis, nor
respiratory burst activity/bacterial killing could be detected. These
findings suggest that internalization is crucial for bacterial killing and
underline the importance of specific Abs for immunity to B. pertussis.
Furthermore, the data indicate that B. pertussis-specific IgG and IgA
reduce the odds for intracellular bacterial survival as suggested by
previous murine infection studies (17, 38).
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